Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share Price

Price 1,876.50p on 30-01-2026 at 19:20:07
Change 24.50p 1.32%
Buy 1,871.00p
Sell 1,870.50p
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Buy 32,045.00 at 1,876.50p
Day's Volume: 8,924,204
Last Close: 1,876.50p
Open: 1,836.00p
ISIN: GB00BN7SWP63
Day's Range 1,823.00p - 1,876.50p
52wk Range: 1,242.50p - 1,909.50p
Market Capitalisation: £75.70b
VWAP: 1,866.34623p
Shares in Issue: 4.03b

Sector: Medicine and Biotech

Listed In: FTSE All-Share, FTSE All-Share ex Investment Trusts, FTSE Higher Yield, FTSE 350 ex Investment Trusts, FTSE 350 , FTSE 100,

Glaxosmithkline (GSK) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 32,045 1,876.50p SI Trade
Negotiated Trade
 16:48:18 - 30-Jan-26
Unknown* 119,760 1,868.60424p Currency Conversion
OTC Trade
 16:42:39 - 30-Jan-26
Sell* 2,009 1,876.50p Automatic Execution
 16:39:20 - 30-Jan-26
Sell* 1,900 1,876.50p Automatic Execution
 16:39:20 - 30-Jan-26
Sell* 200 1,876.50p Automatic Execution
 16:39:20 - 30-Jan-26
Sell* 400 1,876.50p Automatic Execution
 16:39:20 - 30-Jan-26
Sell* 200 1,876.50p Automatic Execution
 16:39:20 - 30-Jan-26
Sell* 400 1,876.50p Automatic Execution
 16:39:20 - 30-Jan-26
Sell* 200 1,876.50p Automatic Execution
 16:39:20 - 30-Jan-26
Sell* 200 1,876.50p Automatic Execution
 16:39:20 - 30-Jan-26
See more Glaxosmithkline trades

Glaxosmithkline (GSK) Share Price History

Time period:
to
Date Open High Low Close Volume
30th Jan 2026 (Fri) 1,836.00 1,876.50 1,823.00 1,876.50 8,924,204
29th Jan 2026 (Thu) 1,812.00 1,859.00 1,811.00 1,852.00 9,993,355
28th Jan 2026 (Wed) 1,842.50 1,851.50 1,810.00 1,817.50 12,027,944
27th Jan 2026 (Tue) 1,834.00 1,865.50 1,832.50 1,862.50 4,702,280
26th Jan 2026 (Mon) 1,802.50 1,833.00 1,795.00 1,828.50 3,634,721
23rd Jan 2026 (Fri) 1,814.00 1,814.00 1,796.00 1,801.00 9,062,710
22nd Jan 2026 (Thu) 1,792.50 1,808.00 1,776.50 1,804.50 4,820,384
21st Jan 2026 (Wed) 1,786.50 1,798.50 1,777.00 1,787.50 6,414,843
20th Jan 2026 (Tue) 1,802.00 1,805.50 1,774.00 1,795.50 7,498,672
19th Jan 2026 (Mon) 1,800.00 1,816.00 1,793.00 1,816.00 5,056,429
16th Jan 2026 (Fri) 1,838.00 1,845.00 1,795.50 1,816.50 14,632,764
15th Jan 2026 (Thu) 1,890.50 1,895.50 1,845.00 1,848.00 4,980,454
14th Jan 2026 (Wed) 1,856.50 1,880.50 1,853.50 1,880.50 6,552,424
13th Jan 2026 (Tue) 1,868.50 1,874.00 1,833.00 1,858.00 5,789,190
12th Jan 2026 (Mon) 1,879.50 1,902.00 1,866.00 1,877.00 5,647,857
9th Jan 2026 (Fri) 1,875.00 1,896.00 1,871.00 1,886.00 6,348,596
8th Jan 2026 (Thu) 1,891.50 1,908.50 1,880.00 1,891.00 6,026,419
7th Jan 2026 (Wed) 1,902.00 1,909.50 1,869.50 1,901.50 7,532,634
6th Jan 2026 (Tue) 1,818.00 1,905.50 1,817.50 1,899.50 11,458,875
5th Jan 2026 (Mon) 1,846.00 1,847.00 1,800.00 1,820.50 5,344,789
2nd Jan 2026 (Fri) 1,828.00 1,849.00 1,821.00 1,831.50 5,188,093
1st Jan 2026 (Thu) 1,824.50 1,824.50 1,824.50 1,824.50 0
31st Dec 2025 (Wed) 1,833.50 1,835.00 1,824.50 1,824.50 2,468,218
See more Glaxosmithkline price history

Glaxosmithkline (GSK) Regulatory News

Date Source Headline
26th Jan 2026 7:00 am RNS European Commission approves Arexvy for adults 18+
20th Jan 2026 7:05 am RNS GSK to acquire RAPT Therapeutics
20th Jan 2026 7:00 am RNS Agreement on changes to ViiV minority shareholding
16th Jan 2026 3:30 pm RNS Director/PDMR Shareholding
15th Jan 2026 3:30 pm RNS Director/PDMR Shareholding
13th Jan 2026 3:30 pm RNS Director/PDMR Shareholding
7th Jan 2026 7:05 am RNS EC approval of Shingrix PFS
7th Jan 2026 7:00 am RNS Positive phase 3 data for GSK's bepirovirsen
6th Jan 2026 7:00 am RNS Exdensur approved in Japan
5th Jan 2026 3:30 pm RNS Director/PDMR Shareholding
See more Glaxosmithkline regulatory news

Glaxosmithkline (GSK) Share News

LONDON MARKET CLOSE: Stocks mixed amid tech earnings, Fed fallout

29th Jan 2026 17:06

(Alliance News) - Stock prices in London closed mostly higher on Thursday, as investors digested the US Federal Reserve's Wednesday decision to stand pat on interest rates. Read More

AstraZeneca plots bumper China investment in "exciting next chapter"

29th Jan 2026 10:29

(Alliance News) - Pharmaceutical firm AstraZeneca PLC on Thursday unveiled plans to invest USD15 billion in China through to 2030, in an announcement that coincides with UK Prime Minister Keir Starmer's visit to Beijing. Read More

UK earnings, trading statements calendar - next 7 days

28th Jan 2026 13:01

Read More

LONDON BROKER RATINGS: BofA raises St James's Place and Quilter

27th Jan 2026 09:44

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More

LONDON BRIEFING: Sage quarterly revenue up; Dr Martens sales decline

27th Jan 2026 07:59

(Alliance News) - The UK pub sector awaits a GBP100 million support package from the Treasury aimed at easing cost pressures, the Financial Times reports, while Sage posts 10% quarterly revenue growth and Dr Martens reports a dip in third-quarter revenue. Read More

See more Glaxosmithkline news
FTSE 100 Latest
Value10,223.54
Change51.78

Login to your account

Forgot Password?

Not Registered